Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter ended June 30, 2018
Filing Date: July 31, 2018
This filing serves as a notification that the Company issued a Press Release on July 31, 2018, announcing its second-quarter financial results. The detailed financial figures and press release are provided as Exhibits 99.1 and 99.2, respectively, and are not fully reproduced in the body of this Form 6-K.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibits (99.1 and 99.2).
The Company utilizes the following non-GAAP financial measures to supplement IFRS results:
- EBITDA (Operating income excluding interest, taxes, depreciation, and amortization)
- Delivered operating income (Earnings before interest and taxes)
- Free cash flow
- Results presented in constant currency
Material Changes
The filing text does not explicitly state material changes versus the prior comparable period. Investors must refer to the attached Press Release (Exhibit 99.1) and financial figures (Exhibit 99.2) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company states that non-GAAP measures are provided to enhance the user's understanding of current financial performance and future prospects. These measures are intended to provide consistency and comparability with prior periods.
Regulatory Note: The Company emphasizes that non-GAAP measures should not be used as a substitute for or considered superior to GAAP (IFRS) financial measures. Reconciliations between non-GAAP and IFRS measures are included in the attached Press Release and Cash Flow Statement.
Legal Status of Exhibits: The attached Exhibits are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to the liabilities of that section. They are not incorporated by reference in any other filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2018 revenue, EBITDA, and free cash flow figures.
- Examine Exhibit 99.2 for the detailed reconciliation of non-GAAP measures to IFRS standards.
- Verify the impact of currency fluctuations by comparing reported results with constant currency results in the exhibits.
- Confirm that the non-GAAP metrics align with the Company's historical reporting methodology.